Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2010, Issue , 2010, Pages 153-159

  Logan, Aaron C ^a   Goodnough, Lawrence T ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

CHEMICALLY INDUCED DISORDER; HUMAN; OFF LABEL DRUG USE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME;

FACTOR VIIA; GUIDELINES AS TOPIC; HUMANS; OFF-LABEL USE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 79955026271     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2010.1.153     Document Type: Review

References (0)